Swiss Biotech Report 2006

More documents

Recommendations

Info

IMPRESSUMSteering Committee:Jürg Zürcher, Ernst &Young Ltd., BaselMarkus Bernhard, Ernst &Young Ltd., ZurichDaniel Guntli, seco/Location Switzerland, BernRegula Bärtschi, seco/Location Switzerland, BernOreste Ghisalba, KTI/CTI, BernHeinz Müller, Swiss Federal Institute of IntellectualProperty, BernYvonne Wegmann, SWX Swiss Exchange, ZurichDomenico Alexakis, Swiss Biotech Association,Bern and ZurichProject Management/Concept/Content:Alexandra Escher Clauss,Xandracom GmbH, WinterthurLayout/Design:Stefanie Keller, Keller Construction, ZurichPrint: SäntisPrint AG, UrnäschPhotos: Provided by the companies and FlurinaRothenberger, Zurich (pages 8, 9, 12, 28, 30) /Helsinn, Lugano (page 20)Artikel-Nr. seco SE-324-BRO-E-A4
Page 2 and 3: 02 WHY SWITZERLAND?USEFUL ADDRESSES
Page 4 and 5: 04BIOTECH COUNTRYSWITZERLANDBIO VAL
Page 6 and 7: 06 A PRIME BUSINESS LOCATION... >>
Page 8 and 9: 08 INDUSTRY STATEMENTSERNESTOBERTAR
Page 10 and 11: 10WHAT KEEPS SWISS... >>THE INNOVAT
Page 12 and 13: 12AN EXPONENTIAL INCREASE IN STRENG
Page 14 and 15: 14 ... AND CONCENTRATING ... >>•
Page 16 and 17: 16 PARTIAL REVISION OF SWISS PATENT
Page 18 and 19: 18BIOTECH PROJECTS ATTRACT... >>SEC
Page 20 and 21: 20LICENSED FOR SUCCESSHELSINN This
Page 22 and 23: 22... ONE BIOTECH CLUSTER“WHITE B
Page 24 and 25: 24>>biotech IPO continue to be rela
Page 26 and 27: 26SWISS BIOTECH INDUSTRY...INDUSTRY
Page 28 and 29: 28COMPETITION FOR ANTIBODIESMOLECUL
Page 30 and 31: 30PROGRAMMED DEATH FOR TUMOUR CELLS
Page 32 and 33: 32APPENDIX: FACTS AND FIGURESSwitze
Page 34 and 35: 34INDUSTRY SEGMENTATION OF THE138 B

Swiss Biotech Report 2006

Create successful ePaper yourself

Delete template?

Save as template?